Related Experiment Video
Updated: Jun 25, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
CCR9 and inflammatory bowel disease
Christian Koenecke1, Reinhold Förster
1Institute of Immunology, Hannover Medical School, Carl-Neuberg-Str.1, D-30625 Hannover, Germany.
Background:
The pathological features of inflammatory bowel disease (IBD) are associated with leukocyte cell infiltrates, which contribute to disease progression and persistence by production of proinflammatory mediators. Recruiting leukocytes to the gut involves local expression of chemokines that interact with receptors on the leukocytes' surface. Specific antagonists may interfere with leukocyte recruitment to the intestine. The chemokine receptor CCR9 is one of the key molecules in leukocyte homing to gut mucosa. CCR9 antagonists have been shown to retard progression in patients with IBD.
Objective:
To discuss CCR9 as a potential target for the treatment of IBD.
Methods:
A literature review.
Results/Conclusions:
The therapeutic effects of CCR9 antagonists, in combination with established therapies, should be evaluated in an attempt to slow down leukocyte recruitment at early stages of IBD.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Introduction
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

